Browse products

Related products

more on pharma »
more on Central and Eastern Europe »

Central Europe Pharma News

12-month subscription (26 issues of biweekly news)
Central Europe Pharma News 12-month subscription (26 issues of biweekly news)

Subscription: 1 year

Delivery: PDF


Our clients say... 
“PMR's analysts understand our needs well and the standard of their service has always fully met our expectations. We are looking forward to cooperating with PMR in the future as well. ” Senior Trade and Investment Adviser, British Embassy in Warsaw
“We consider PMR a competent and professional company. PMR analysts understand our needs clearly and their services have fully met our expectations. I strongly recommend the company as a reliable partner in providing economic information and market analysis.” General Manager, Sanofi-Synthelabo
“I have been using PMR news update services for a few months and I appreciate their professionalism, kindliness of the staff, punctuality and quality of materials. I would strongly recommend the news update services as it is an economical way to save in-house company resources.” Senior Analyst, Beragua Capital Advisory
“I am very satisfied with the service that PMR provides us. Our business needs up-to-date information as we would like to catch all the opportunities in our fast-growing markets. I receive all the important news about CEE and Russia from one source and gain insight from PMR markets analysis. I can recommend PMR as a partner to all companies who wish to make business on a professional level in this region.” Development Director, Baltika Group
“We use PMR's services due to their analysts' extensive experience in market analysis, their high quality and level of engagement in the market research carried out for us. We consider PMR a competent and professional company and recommend them as a reliable partner in the area of economic information and market analysis.” Senior Trade and Investment Adviser, British Embassy in Warsaw
“I really appreciate regularly receiving the most significant market information of our principal marketing area in a consolidated format. The PMR services include not only an accurate level of detail, but also have central instruments such as a subject index and an abstract for the conclusion, allowing a fast orientation. ” Chief Marketing Officer, Eisberg Group
“As a London-based company, with operations abroad, we looked for the best-in-class Market Intelligence supplier. PMR brought us quality reports that improved our CEE market knowledge and understanding.” Development Manager, GVA Grimley
“Sanofi-Aventis group regularly order PMR's reports and newsletters concerning the Polish pharmaceutical market. We use PMR's services because of the wealth of experience of its analysts in undertaking market analysis and a high level of quality and involvement in the field of market research. ” General Manager, Sanofi-Synthelabo
“The information provided is very up-to-date and keeps us in the loop. Switching from pdf to online access proved to deliver even better results. We would always recommend PMR as a one-stop shop for all you need to know before making any decision. Thanks for all your efforts. ” Development Manager, GVA Grimley
“It's a great pleasure to cooperate with PMR because of its analysts' wealth of experience in understanding the local market. We consider PMR a competent and professional company which helps us conduct our business. I would also like to state that PMR's team is always ready to respond to emerging customer needs. We can recommend it as a reliable partner.” Business Analyst, Hilti Distribution, Russia

Central Europe Pharma News is a bi-weekly newsletter, delivered PDF format directly to your inbox, covering the pharmaceutical sector in Bulgaria, Czech Republic, Hungary, Poland, Slovakia and Romania. Senior executives in pharmaceutical companies and those planning to invest in the CEE healthcare sector, benefit from news, analysis and commentary on the pharmaceutical sector in Central Europe.

Published every second Wednesday, Central Europe Pharma News provides an excellent resource to support the individual needs of the reader with outstanding provision of reference material that is trusted in a light format. Each issue contains up to 65 short articles and news stories and 15 country specific stories, an in-depth analytical article, an expert commentary, a list of upcoming events and a company index .    

This newsletter is also available as an online service - Central Europe Pharma Online.
  Cece
 Compare PDF to online access.

Country specific news and viewpoints at your fingertips

News stories are grouped by country and viewpoints – market, R&D and medical and company news - so that subscribers can access the most relevant information quickly and easily .

  • Market news - covers pharmaceutical market size; legislative changes to healthcare law; drug and reimbursement policies; drug pricing; regulatory updates and drug and healthcare financing.
  • R&D and Medical news – reports on diseases, clinical trials, biotechnology, research and development; planned investments in the healthcare sector and the development of the private healthcare market and regulatory framework for health insurance; new medical devices and investment in healthcare units, clinic and hospital modernisation.  
  • Company news – covers companies active in the pharmaceutical and healthcare market, mergers and acquisitions, partnership agreements, new drug launches, future development plans and new CEO and CFO appointments. Companies include drug manufacturers and distributors, healthcare insurance companies and medical equipment manufacturers.

Feature articles and commentaries for industry insight and opinion

Each newsletter issue includes an in-depth feature article providing an analysis of the CEE pharmaceutical market as a whole or of a specific country in the region. Some of the previous articles have included analysis of specific pharmaceutical market segments, the impact of economic crisis on the pharmaceutical industry in the region, medicine consumption alongside regulatory issues, health financing and insurance.

An expert commentary, delivered by PMR analysts or external industry experts, and included in the newsletter, provides an analysis of major developments in the market, how regulatory changes affect the industry and major events taking place.

Sample feature article titles included:

  • The OTC market in Central and Eastern Europe will be worth more than €12bn in 2012
  • Polish market of clinical trials poised to grow 5% in 2010
  • Impact of regulatory fees on medicines consumption in the Czech Republic

Sample expert commentary topics included:

  • Healthcare reform in the Czech Republic
  • New rules limited new pharmacy openings in Hungary
  • New investments of Gedeon Richter

Industry professionals and their businesses benefit from CEPN

Senior executives of pharmaceutical and healthcare companies, suppliers and distributors of medical products and equipment, financial, legal, consulting, government, research and education professionals choose Central Europe Pharma News as credible, objective and trusted source of information to monitor market progress and keep informed about trends and developments across the region.

The newsletter has been appreciated by our partner:

'Central Europe Pharma News is a good tool for every stakeholder in the pharmaceutical industry that is interested in the region. It summarizes the most important developments on the market including the most significant legislative changes and gives you an overview of the major issues that have been debated in the region. The newsletter is comprehensive and well-structured.'

Attorney at Baker&McKenzie, Budapest

Annual subscribers to CEPN and their businesses benefit from:

  • Regular news updates on pharmaceutical and healthcare sector in Central and Eastern Europe
  • Latest market, company, R&D and medical news
  • Current trends and market analysis on the pharmaceutical industry in the CEE region
  • Legal and regulatory updates and regulations governing the pharmaceutical sector
  • Upcoming pharmaceutical and healthcare conferences and trade shows

Request more info/free trial

To receive more information on this newsletter, please sign up.

*required

*Would you like a FREE
interactive screenshare?
*Email:
To make sure you receive the requested information, add info@pmrcorporate.com to your company trusted emails. Contact your IT department for details.
*Your company core business:

Privacy Policy

Central Europe Pharma News
12-month subscription (26 issues of biweekly news)

Choose your version of this product:

Select
language: 		Select
licence: 		     Price: 1100 €
Language / Licence Single 5 Users Corporate Global
English1100€1600€2400€3200€

Compare licences
  • "Single user licence" entitles the client to use the product (in its entirety or in part, and in the case of an online product also to use the access data to this product) only and exclusively in the following fields of exploitation:
    • - for the product preservation: saving the product in the memory of one computer belonging to the client;
    • - for multiplying and making the product available: multiplication of the product by production of its copies either by printing or by digitalisation (e.g. on a disc, CD-ROM, DVD, magnetic tape, magneto-optic carrier, print and electronic devices, including electronic paper) for the individual use of one person only, who is indicated by the client during purchasing process.

      Any other preservation, multiplication, copying and dissemination etc. which is beyond the scope of this licence is strictly forbidden.
  • "5-user licence" entitles the client to use the product (in its entirety or in part, and in the case of an online product also to use the access data to this product) only and exclusively in the following fields of exploitation:
    • - for the product preservation: saving the product in the memory of 2 to 5 computers belonging to the organisation indicated by the client while purchasing process; these computers must be located in the same country as the organisation indicated during purchasing process;
    • - for multiplying and making the product available: multiplication of the product by production of its copies either by printing or by digitalisation (e.g. on a disc, CD-ROM, DVD, magnetic tape, magneto-optic carrier, print and electronic devices, including electronic paper) for 2 to 5 people who work for the organisation indicated by the client during purchasing process, and who are in the same country as the organisation indicated during purchasing process.

      Any other preservation, multiplication, copying and dissemination etc. which is beyond the scope of this licence is strictly forbidden.
  • "Corporate licence" entitles the client to use the product (in its entirety or in part, and in the case of an online product also to use the access data to this product) only and exclusively in the following fields of exploitation:
    • - for the product preservation: saving the product in the memory of an unlimited number of computers belonging to the organisation indicated by the client during purchasing process; these computers must be located in the same country as the organisation indicated during purchasing process;
    • - for multiplying and making the product available: multiplication of the product by production of its copies either by printing or by digitalisation (e.g. on a disc, CD-ROM, DVD, magnetic tape, magneto-optic carrier, print and electronic devices, including electronic paper) for an unlimited number of people who work for the organisation indicated by the client during purchasing process, who are in the same country as the organisation indicated during purchasing process.

      Any other preservation, multiplication, copying and dissemination etc. which is beyond the scope of this licence is strictly forbidden.
  • "Global licence" entitles the client to use the product (in its entirety or in part, and in the case of an online product also to use the access data to this product) only and exclusively in the following fields of exploitation:
    • - for the product preservation: saving the product in the memory of an unlimited number of computers belonging to the organisation indicated by the client during purchasing process; these computers can be located in or outside of the country of the organisation indicated during purchasing process;
    • - for multiplying and making the product available: multiplication of the product by production of its copies either by printing or by digitalisation (e.g. on a disc, CD-ROM, DVD, magnetic tape, magneto-optic carrier, print and electronic devices, including electronic paper) for an unlimited number of people who work for the organisation indicated by the client during purchasing process, who are in or outside of the country of the organisation indicated during purchasing process.

      Any other preservation, multiplication, copying and dissemination etc. which is beyond the scope of this licence is strictly forbidden.
    PMR is a member of SIIA's Corporate Content Anti-Piracy Program. Breaking the conditions of our licences will result in a report being sent to SIIA to initiate a piracy investigation and major fees may be imposed by the SIIA as a result. Additionally, for newsletters and online services, it will result in suspension of the subscription with no money refund.